1 2-dihydroquinolyl))he xa-1,3,5-trienyl]amino]aminomethane-1-thione (10) exhibited activity at 5.0-10.

2 re suspended in a dilute tris(hydroxymethyl)-aminomethane/2-(N-morpholino) ethanesulfonic acid buffer

3 oxy-4,5-dihydro-3H-naphtho[1,8-bc]furan-5-yl)aminomethane, 6b, had K(i) values for displacement of [(

4 increasing plasma sodium, tris-hydroxymethyl aminomethane acts by increasing plasma weak base concent

5  to 1 mM, using the bases tris(hydroxymethyl)aminomethane, ammonia, carbonate, hydroxide, hydrogen ph

6  Tris-acetate-EDTA; Tris, tris[hydroxymethyl]aminomethane) buffer.

7 rm at 2.4 A resolution; a tris(hydroxymethyl)aminomethane-Co(II)-enzyme complex structure at 1.8 A re

8 pecifically, we developed tris(hydroxymethyl)aminomethane-modified bioadhesive nanoparticles (Tris-BN

9 brane functionalized with tris(hydroxymethyl)aminomethane (P-Tris) was used in affinity membrane chro

10 roxide oxidation of Tris [tris(hydroxymethyl)aminomethane] present in transcription buffer and spermi

11                           Tris-hydroxymethyl aminomethane (THAM) may be an effective method to contro

12 ased on pyridine (py) and tris(hydroxymethyl)aminomethane (TRIS) are catalytically inactive.

13     The organic compounds tris(hydroxymethyl)aminomethane (Tris), urea, dithiothreitol (DTT), glycero

14 alone and in complex with tris(hydroxymethyl)aminomethane (Tris), which, like the phosphorylethanolam

15 standard buffers, such as tris(hydroxymethyl)aminomethane (Tris).

16 sphate in the presence of tris(hydroxymethyl)aminomethane (Tris).

17 r of N-formylglycine with Tris(hydroxymethyl)aminomethane, with the rate of peptidyl transfer by the